OHSU-PSU School of Public Health at IDWeek 2026

Oct 21–24, 2026 Washington, DC ~12k attendees Website

OHSU-PSU School of Public Health brings 2 presentations to IDWeek 2026 in Washington. Its program centres on Mycobacterium avium complex lung disease. One study reports amikacin and macrolide resistance in newly diagnosed patients from ENCORE, and another draws on real-world evidence about what drives treatment and how patients fare.

OrganizationIDWeek 2026 Attendance
Talk
Thu Oct 22
10:30am–10:42am
Part of Late Breaking Abstracts: Antimicrobials
Amikacin and Macrolide Resistance in Patients With Newly Diagnosed Mycobacterium avium Complex Lung Disease: Results From ENCORE
206
Antimicrobials, resistance and stewardshipRespiratory infections and COVID-19
Poster
Sat Oct 24
12:15pm–1:30pm
Real-World Evidence of Treatment Drivers and Outcomes in Patients Diagnosed with Mycobacterium avium Complex Lung Disease (MACLD)
Poster Hall B-C · Poster P-475
C5. Respiratory infections - bacterial

Explore the full IDWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full IDWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from OHSU-PSU School of Public Health

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction